Skip to content

The study of primary percutaneous coronary intervention (PCI) with ancillary intra-aortic balloon counterpulsation (IABP) in high-risk patients of ST-segment elevation myocardial infarction(STEMI)

The study of primary percutaneous coronary intervention (PCI) with ancillary intra-aortic balloon counterpulsation (IABP) in high-risk patients of ST-segment elevation myocardial infarction(STEMI)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-ICR-15006956
Enrollment
Unknown
Registered
2015-08-23
Start date
2015-09-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ST-segment elevation myocardial infarction

Interventions

control:primary PCI
intervention:IABP+primary PCI

Sponsors

The Affiliated DrumTower Hospital, Nanjing University Medical School
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: STEMI patients regardless of symptoms onset time; definite indication of primary PCI; patients accept PCI voluntarily; high-risk score >=3 points: 1.symptoms onset time>=6 hours(1 point); 2. anterior myocardial infarction (1 point); 3. Killips class II/III or pumonary eadema confirmed by X-ray or PO2=100bpm(1 point); 5. left main artery as infarct-related artery(3 points); 6. saphenous vein graft as target vessel of Primary PCI (2 points); 7. recurrence of myocardial infarction (2 points); 8. TIMI grade 0-1 of infarct-related artery accompanied with another artery stenosis>=90% in proximal or middle segment(1 point).

Exclusion criteria

Exclusion criteria: Bleeding; cardiac shock; resuscitation more than 30min; severe peripheral artery diseases; moderate to severe regurgitation of aortic valve; aortic or peripheral artery dissection; pregnancy; blood pressure>=140/100mmHg; mechanical complication of AMI; randomization is not permitted according to the disease; informed consent is not acquired.

Design outcomes

Primary

MeasureTime frame
all-cause death;

Secondary

MeasureTime frame
major adverse cardiovascular events;cardiac function;

Countries

China

Contacts

Public ContactXU Biao
xubiao@medmail.com.cn+86 13505193257

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026